Oxycodone IR Tablets: Food Administration Guidance
Oxycodone immediate-release tablets can be taken with or without food, though taking them with food increases drug absorption by approximately 27% and delays time to peak concentration. 1
Key Pharmacokinetic Evidence from FDA Labeling
The FDA drug label provides definitive pharmacokinetic data from a single-dose food effect study in healthy volunteers using oxycodone solution 1:
- With high-fat meal: AUC increased 27% (from 105 to 133 ng×hr/mL), indicating enhanced drug absorption
- Time to peak concentration (Tmax): Delayed from 1.25 hours (fasted) to 2.54 hours (fed)
- Peak concentration (Cmax): Slightly decreased from 19.0 to 17.7 ng/mL
- Similar effects expected with 15 mg and 30 mg tablets 1
Clinical Implications
The food effect is clinically significant but does not contraindicate administration with food. The 27% increase in total drug exposure means:
- Patients taking oxycodone consistently with meals will have higher steady-state levels
- Taking doses inconsistently (sometimes with food, sometimes without) may cause fluctuating blood levels
- The delayed Tmax with food means slower onset of analgesia but potentially longer duration
Practical Recommendations
For optimal pain management, establish a consistent pattern:
- If starting therapy: Choose either always with food or always without food, then maintain that pattern
- For fastest pain relief: Take on empty stomach (onset ~1.25 hours vs 2.5 hours with food)
- For patients with opioid-induced nausea: Taking with food may help tolerability, but be aware this increases total drug exposure by 27%
Important caveat: The common clinical practice of recommending opioids with food to reduce nausea lacks strong evidence. A 2017 systematic review found that taking opioids with food does not consistently reduce nausea and vomiting, and in many cases actually increases these adverse events 2. This contradicts widespread clinical assumptions.
Dosing Adjustments
If switching between fed and fasted states, consider that the 27% increase in AUC with food is roughly equivalent to a dose increase. Monitor patients for:
- Increased sedation or respiratory depression when switching from fasted to fed administration
- Inadequate analgesia when switching from fed to fasted administration
The FDA label does not require dose adjustment based on food intake, but clinical judgment should account for the pharmacokinetic differences 1.
Contrast with Controlled-Release Formulations
Notably, controlled-release oxycodone shows no significant food effect on bioavailability, with 90% confidence intervals for AUC and Cmax falling within acceptable ranges under fed versus fasted conditions 3. This represents a key difference between immediate-release and controlled-release formulations.